Mediassist Healthcare IPO GMP, Details, Guidance, Subscription Status, allotment @ Chanakyanipothi.com
👉A legacy of 31 Years.
India`s Oldest Investment & IPO website.
👉Most Trusted by Investors across India.
Table of Contents
- GMP
- Reviews
- Subscription
- Allotment
Post listing Review of Mediassist Healthcare IPO?
Listed at Rs. 450, at premium of 10.05% over the issue price. The listing has been below the expectations of the grey market.
What are the promoters of Mediassist Healthcare IPO?
DR. VIKRAM JIT SINGH CHHATWAL, MEDIMATTER HEALTH MANAGEMENT PRIVATE LIMITED AND BESSEMER INDIA CAPITAL HOLDINGS II LTD are the promoters of the Mediassist Healthcare.
What are the Objects of Mediassist Healthcare IPO?
The Issue comprises only of Offer for sale.
The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer for Sale
Subscription Status of Mediassist Healthcare IPO?
On 17 January 2024 5.00 pm (Day 3) (Closed)
Review: subscription trend improved in last one hour.
QIB: 5605634 Shares 40.14 T
NII(10L+): 2802817 Shares 17.22 T
NII (<10L) 1401409 Shares 10.12 T
NII (Total) 4204226 Shares 14.85 T
RII: 9809859 Shares 3.19 T
Total: 19619719 Shares 16.25 T
What is the business of Mediassist Healthcare?
Mediassist Healthcare is India’s largest health benefits administrator in terms of revenues in the Financial Years 2021, 2022 and 2023. Its primary clients are insurance companies; however, it also serves as an
intermediary between (a) general and health insurance companies and the insured members, (b) insurance companies and healthcare providers (such as hospitals), and (c) the Government and beneficiaries of public health schemes. For the Financial Year 2022, its total revenues accounted for 24.89%, its EBITDA accounted for 40.88%, and its profit after tax accounted for 55.31%, of the Indian health benefits administration industry revenue, EBITDA and profit after tax, respectively.
It is also the largest health benefits administrator in India in terms of premium under management for retail and group policies, with a market share of 14.83% of the retail health insurance market and 41.71% of the group health insurance market, and combined retail and group segment share of 33.67% serviced by health benefits administrators for the Financial Year 2022. It managed Rs.145,746.49 million of health insurance premiums (group and retail) as at the end of Financial Year 2023 growing at a CAGR of 35.67% from Rs.79,184.93 million as at the end of Financial Year 2021. As of March 31, 2023, we work with 36 insurance companies in India and globally.
Its technology costs (operating costs and capital expenditure) were Rs.49.57 million, Rs.18.32 million and Rs.202.19 million for the Financial Years 2021, 2022 and 2023, respectively, and aggregated to 1.54%, 0.47% and 4.00% of its revenue from contracts with customers, respectively.
It is the largest health benefits administrator in India in terms of premium under management for retail and group schemes. It serviced over 9,500 group accounts across sectors to help administer
the insurance requirements of their employees. As of March 31, 2022, it managed around Rs.96 billion of group health insurance premiums, representing 26.01% of India’s overall group health insurance market and 41.71% of the group health insurance market serviced by health benefits administrators in Financial Year 2022. Its market share in the overall group health insurance market serviced by health insurance market serviced by health benefits administrators was nearly five times that of its nearest competitor in the Financial Year 2022
For more information, click www.mediassist.in
Mediassist Healthcare IPO GMP, Particulars & Guidance
Mediassist Healthcare IPO Details | |
IPO opens on | 15 January 2024 |
IPO closes on | 17 January 2024 |
Issue Type | Book Built Issue IPO |
Issue Size | 28,028,168 Sh /Rs 1171.58 Cr |
* Fresh Issue | – Sh /Rs – Cr |
* Offer for Sale | 28,028,168 Sh /Rs 1171.58 Cr |
Face Value per share: | Rs. 5 |
Price Band | Rs. 397-418 |
Retail Discount | Rs 0 per share |
Employee discount | Rs. 0 per share |
Retail Lot Size | 35 Shares |
Listing will at | BSE, NSE |
Shares offered in Mediassist Healthcare? | Shares | Rs. in Cr |
QIB (50 %) | 14014084 | 585.59 |
NII (15 %) | 4204225 | 175.74 |
RII (35 %) | 9809859 | 410.05 |
Employees | – | – |
Total Shares | 28028168 | 1171.58 |
Retail portion will be oversubscribed by | 280281 Forms. | |
How to apply in Mediassist Healthcare IPO ? | Amount Rs. | |
Min Retail Application | 35 Sh | 14630 |
Max Retail Application | 455 Sh | 190190 |
Small HNI (Min) application | 490 Sh | 204820 |
Small HNI (Max) application | 2380 Sh | 994840 |
Big HNI Application | 2415 Sh | 1009470 |
What is the timetable of Mediassist Healthcare IPO? | |
IPO opens on | 15 January 2024 |
IPO Closes on | 17 January 2024 |
IPO Allotment on | 18 January2024 |
Unblocking of ASBA | 19 January 2024 |
Credit of Shares | 19 January 2024 |
Listing on | 22 January 2024 |
Registered Office of Mediassist Healthcare | |
Tower D, 4th floor, IBC Knowledge Park, 4/1 Bannerghatta Road, Bengaluru 560 029, Karnataka, India | |
Who are the Lead Managers of Mediassist Healthcare IPO? Axis Capital Limited IIFL Securities Limited Nuvama Wealth Management Limited (formerly known as Edelweiss Securities Limited) SBI Capital Markets Limited | |
Registrar to IPO | |
Link Intime India Private Limited |
Mediassist Healthcare IPO Financial & Analytical Ratios | ||||
Year | Total Income | Net Profit | EPS | RoNW |
Rs. in Cr | Rs.in Cr | Rs. | % | |
2020-21 | 345.57 | 38.00 | 5.67 | 12.99 |
2021-22 | 412.02 | 63.47 | 9.22 | 18.71 |
2022-23 | 518.95 | 75.31 | 10.94 | 19.63 |
Book Value of the Share on 31.03.2023 | Rs. | 55.72 | ||
BV of the Share after the FPO | Rs. | ? | ||
Offer Price at Cap | Rs. | 418 |
Mediassist Healthcare IPO Ratio Analysis | |
Price /EPS | 38.60 |
Price/Book Value Ratio | 7.50 |
Price/BV after IPO | ? |
How Mediassist Healthcare IPO compares with the Peers?
Peer Comparison.
There are no listed companies in India that engage in a business similar to that of this Company and its Subsidiaries. Accordingly, it is not possible to provide an industry comparison in relation to this Company.
As on date of DRHP | FV | Total | PE |
Rs. | Income | Ratio of | |
Rs. In Cr | |||
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Mediassist Healthcare IPO Guidance
This is the much-awaited IPO. Mediassist Healthcare is India’s largest health benefits administrator in terms of revenues in the Financial Years 2021, 2022 and 2023. Its primary clients are insurance companies; however, it also serves as an intermediary between (a) general and health insurance companies and the insured members, (b) insurance companies and healthcare providers (such as hospitals), and (c) the Government and beneficiaries of public health schemes.
As of March 31, 2022, it managed around Rs.96 billion of group health insurance premiums, representing 26.01% of India’s overall group health insurance market and 41.71% of the group health insurance market serviced by health benefits administrators in Financial Year 2022.
The shares in this IPO are offered at very reasonable valuation of 38.60. The business has strong growth potential. Considering the growth potential and the valuation at which the shares are offered, we strongly recommend this IPO. Apply with FF (Full Force).
Quicklinks
Mediassist Healthcare IPO GMP
Mediassist Healthcare IPO GMP today details
Mediassist Healthcare IPO GMP today, Details, Guidance, Subscription Status, allotment
Mediassist Healthcare IPO Anchor Investors details
Medi Assist Healthcare Services IPO: Anchor investors buy Rs 351 crore of shares
Medi Assist Healthcare Services, the Bengaluru-based health insurance third-party administrator, mobilised Rs 351.5 crore through its anchor book issue ahead of the IPO opening. The public issue will open next week on January 15 and will close on January 17.
Marquee names in the list of anchor investors included Nomura Trust, Goldman Sachs, Ashoka Whiteoak, Pinebridge Global Funds, Troo Capital, and HSBC.
Further, HDFC Mutual Fund, Kotak Mahindra Trustee, Aditya Birla Sun Life Trustee, SBI Life Insurance Company, Mirae Asset, Canara Robeco Mutual Fund, Tata Mutual Fund, Sundaram Mutual Fund, Bandhan Mutual Fund, Edelweiss Trusteeship, Bajaj Allianz Life Insurance Company, Max Life Insurance Company and SBI General Insurance Company among domestic investors also participated in the anchor book, which was launched for a day on January 12.
The healthtech firm in consultation with the book-running lead managers has finalised the allocation of 84,08,449 equity shares to anchor investors at Rs 418 per share.